Authors

• Anders Hviid (ORCID: https://orcid.org/0000-0002-7509-9127)
• Emilia Myrup Thiesson (ORCID: https://orcid.org/0000-0001-6258-4177)
• Nicklas Pihlström (ORCID: https://orcid.org/0000-0001-6812-0971)
• Ulrike Baum (ORCID: https://orcid.org/0000-0002-7456-8016)
• Eero Poukka (ORCID: https://orcid.org/0000-0001-5776-5897)
• Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
• Kristýna Faksová (ORCID: https://orcid.org/0009-0007-8900-5017)
• Tuija M. Leino (ORCID: https://orcid.org/0000-0003-0501-8333)
• Rickard Ljung (ORCID: https://orcid.org/0000-0002-0654-4530)

Institutions

• Statens Serum Institut (DK)
• Medical Products Agency (SE)
• University of Helsinki (FI)
• Steno Diabetes Centers (DK)
• Copenhagen University Hospital (DK)
• Gentofte Hospital (DK)
• Rigshospitalet (DK)
• Karolinska Institutet (SE)
• Finnish Institute for Health and Welfare (FI)
• Capital Region of Denmark (DK)
• European Centre for Disease Prevention and Control (SE)

Publication Details

Journal

The Lancet Regional Health - Europe

Published

2025-11-05

DOI

https://doi.org/10.1016/j.lanepe.2025.101518

Primary Topic

Influenza Virus Research Studies

Type

article

Field-Weighted Citation Impact

0.00